Jointown Pharmaceutical Group is the famous Corporate Investor, which was founded in 1999. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Wuhan.
The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Jointown Pharmaceutical Group, startups are often financed by Lighthouse Capital Management, Shunwei Capital, Lilly Asia Ventures. The meaningful sponsors for the fund in investment in the same round are Shunwei Capital, Lighthouse Capital Management, Fosun Group. In the next rounds fund is usually obtained by Shunwei Capital, Lighthouse Capital Management, Fosun Group.
Among the most popular portfolio startups of the fund, we may highlight Singlera Genomics, Hipac.cn. Among the most popular fund investment industries, there are Medical, Apps. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Related Funds
Fund Name | Location |
EA Global Consulting LLC | - |
Elahi Group of Companies | - |
J O Hambro Capital Management Limited | England, London, United Kingdom |
Jain International Trade Organisation(JITO) | - |
Keyrus Innovation Factory | France, Ile-de-France, Levallois-perret |
Labs8 | Kirkland, United States, Washington |
Nanogate | - |
Omega Capital Partners | California, United States, Woodland Hills |
Sumitomo Bank Venture Fund | - |
SURGE Accelerator | Houston, Texas, United States |
Thai Union Group | Samut Sakhon, Samut Sakhon Province, Thailand |
The Accelerator Group | Illinois, United States, Virginia |
The Startup Training | Italy, Lombardy, Milan |
The Tochigi Bank | Japan, Tochigi Prefecture, Utsunomiya |
Voyage Media | Beijing, Beijing, China |
Windsor Private Capital | Canada, Ontario, Toronto |
Xiaomi Industry Fund | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Convalife Pharmaceuticals | $15M | 03 Jan 2023 | Shanghai, Shanghai, China | ||
AMCARELAB | $30M | 09 Jun 2022 | Yuexiu District, Guangdong Province, China | ||
Binhui Biotech | $46M | 19 Apr 2022 | Wuhan, Hubei, China | ||
Binhui Biotech | 18 Apr 2022 | Wuhan, Hubei, China | |||
Singlera Genomics | $60M | 27 Mar 2018 | San Diego, California, United States | ||
Hipac.cn | $50M | 01 Mar 2018 | Shangcheng District, Zhejiang, China | ||
ZYBC | $463K | 01 Sep 2017 | Dongcheng District, Beijing, China | ||
Yibao | $1M | 24 Jul 2017 | Shangcheng District, Zhejiang, China | ||
Hipac.cn | $25M | 01 Jan 2017 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Convalife Pharmaceuticals | $15M | 03 Jan 2023 | Shanghai, Shanghai, China | ||
AMCARELAB | $30M | 09 Jun 2022 | Yuexiu District, Guangdong Province, China | ||
Binhui Biotech | $46M | 19 Apr 2022 | Wuhan, Hubei, China | ||
Binhui Biotech | 18 Apr 2022 | Wuhan, Hubei, China | |||
Singlera Genomics | $60M | 27 Mar 2018 | San Diego, California, United States | ||
Hipac.cn | $50M | 01 Mar 2018 | Shangcheng District, Zhejiang, China | ||
ZYBC | $463K | 01 Sep 2017 | Dongcheng District, Beijing, China | ||
Yibao | $1M | 24 Jul 2017 | Shangcheng District, Zhejiang, China | ||
Hipac.cn | $25M | 01 Jan 2017 | Shangcheng District, Zhejiang, China |